ARTICLE
2023 Vol 2 · No 5
EN 5f50f73561c8
ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY
ОЦЕНКА ЭФФЕКТИВНОСТИ КЛИНИЧЕСКИХ И ФАРМАКОЭКОНОМИЧЕСКИХ АСПЕКТОВ ПРЕПАРАТА ТОПАМАКС У БОЛЬНЫХ ЭПИЛЕПСИЕЙ | EPILEPSIYA BILAN OG'RIGAN BEMORLARDA TOPAMAX DORI VOSITASINING KLINIK VA FARMAKOEKONOMIK ASPEKTLARINING SAMARADORLIGINI BAHOLASH
Research Focus International Scientific Journal, 2(5), 198–202 · ISSN 2181-3833
Annotatsiya
This scientific article concerns epilepsy, a disease widespread in medicine, which is one of the common diseases of the nervous system requiring long-term treatment. According to the statistical data of the European Commission on epilepsy, about 50 million people in the world suffer from epilepsy. The development of epilepsy is caused by hereditary and genetic factors and, following traumas and infectious diseases, by perinatal damage to the brain. At present, the number of patients with epilepsy in European countries is increasing.
Kalit so‘zlar
Epilepsiyatopamax dori vositasikasalliktutqanoq xurujlari
Iqtibos keltirish
Arslonova Rayxon Rajabboevna; Narmetova Sevara Yangiboyevna (2023). ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY. Research Focus International Scientific Journal, 2(5), 198–202. https://doi.org/10.66073/researchfocus.v2i5.247